Literature DB >> 2806372

Direct labeling of rat M3-muscarinic receptors by [3H]4DAMP.

A D Michel1, E Stefanich, R L Whiting.   

Abstract

The muscarinic receptors of rat submaxillary gland, rat heart and rat cortex were directly labeled using the ligand [3H]4-diphenylacetoxy-N-methyl-piperidine methiodide [( 3H]4DAMP). In the rat submaxillary gland, [3H]4DAMP predominantly bound with high affinity (Kd = 0.2 nM) to a population of binding sites that displayed the pharmacology of the M3 muscarinic receptor subtype. In rat heart, [3H]4DAMP labeled the M2 muscarinic receptor with low affinity (Kd = 4 nM). In rat cortex [3H]4DAMP predominantly bound to a population of sites with high affinity (Kd = 0.2 nM). The pharmacology of these sites was consistent with [3H]4DAMP labeling both M1 and M3 muscarinic receptors present in rat cortex with high affinity. These data indicate that [3H]4DAMP represents a useful ligand for selectively labeling the M1 and M3 muscarinic receptor subtypes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2806372     DOI: 10.1016/0014-2999(89)90359-2

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  18 in total

Review 1.  Functional M3 muscarinic acetylcholine receptors in mammalian hearts.

Authors:  Zhiguo Wang; Hong Shi; Huizhen Wang
Journal:  Br J Pharmacol       Date:  2004-05-17       Impact factor: 8.739

2.  Potentiation of sympathetic neuromuscular transmission mediated by muscarinic receptors in guinea pig isolated vas deferens.

Authors:  Samera Iram; Charles H V Hoyle
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-04-05       Impact factor: 3.000

3.  Acetylcholine-dependent upregulation of TASK-1 channels in thalamic interneurons by a smooth muscle-like signalling pathway.

Authors:  Michael Leist; Susanne Rinné; Maia Datunashvili; Ania Aissaoui; Hans-Christian Pape; Niels Decher; Sven G Meuth; Thomas Budde
Journal:  J Physiol       Date:  2017-08-03       Impact factor: 5.182

4.  Mechanism of all-trans-retinal toxicity with implications for stargardt disease and age-related macular degeneration.

Authors:  Yu Chen; Kiichiro Okano; Tadao Maeda; Vishal Chauhan; Marcin Golczak; Akiko Maeda; Krzysztof Palczewski
Journal:  J Biol Chem       Date:  2011-12-19       Impact factor: 5.157

5.  Identification of the muscarinic pathway underlying cessation of sleep-related burst activity in rat thalamocortical relay neurons.

Authors:  Pawan Bista; Sven G Meuth; Tatyana Kanyshkova; Manuela Cerina; Matthias Pawlowski; Petra Ehling; Peter Landgraf; Marc Borsotto; Catherine Heurteaux; Hans-Christian Pape; Thomas Baukrowitz; Thomas Budde
Journal:  Pflugers Arch       Date:  2011-11-15       Impact factor: 3.657

6.  Muscarinic ACh receptor-mediated control of thalamic activity via G(q)/G (11)-family G-proteins.

Authors:  Tilman Broicher; Nina Wettschureck; Thomas Munsch; Philippe Coulon; Sven G Meuth; Tatyana Kanyshkova; Thomas Seidenbecher; Stefan Offermanns; Hans-Christian Pape; Thomas Budde
Journal:  Pflugers Arch       Date:  2008-03-19       Impact factor: 3.657

7.  Regulation of rat mesencephalic GABAergic neurones through muscarinic receptors.

Authors:  François J Michel; Julie M Robillard; Louis-Eric Trudeau
Journal:  J Physiol       Date:  2004-02-06       Impact factor: 5.182

8.  M3 muscarinic receptors mediate pepsinogen secretion via polyphosphoinositide hydrolysis in guinea pig gastric chief cells.

Authors:  K Wada; C Sakamoto; T Matozaki; H Nishisaki; Y Konda; O Nakano; K Matsuda; T Suzuki; M Nagao; M Kasuga
Journal:  Gastroenterol Jpn       Date:  1992-08

9.  Decreased muscarinic receptor binding in the frontal cortex of bipolar disorder and major depressive disorder subjects.

Authors:  A S Gibbons; E Scarr; C McLean; S Sundram; B Dean
Journal:  J Affect Disord       Date:  2008-12-21       Impact factor: 4.839

10.  Loss of [3H]4-DAMP binding to muscarinic receptors in the orbitofrontal cortex of Alzheimer's disease patients with psychosis.

Authors:  S W Y Tsang; P T Francis; M M Esiri; P T H Wong; C P L H Chen; M K P Lai
Journal:  Psychopharmacology (Berl)       Date:  2008-03-30       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.